PACIRA BIOSCIENCES INC (PCRX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for PCRX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PCRX | Chief Financial Officer, Bicycle Therapeutics, Inc.; Independent Director | 46 | ["25 years of financial expertise in the healthcare and biopharmaceutical industry", "Corporate finance leader providing oversight in financial reporting, internal controls, risk management and regulatory compliance", "Expertise in biopharma industry through leading equity research teams", "Insights into market and industry trends", "Senior financial leadership experience in investor relations, corporate communications and corporate strategy", "Proven track record of raising capital as CFO of Bicycle Therapeutics", "Experience in corporate restructurings"] | ["Audit"] | 2025 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PTCT | Director | 46 | ["More than 20 years of experience in healthcare and biotech equity research and investing","Chief Financial Officer of Bicycle Therapeutics PLC since June 2023","Chief Financial Officer of Graphite Bio, Inc. from April 2022 to June 2023","Senior biotech analyst and head of research at Cantor Fitzgerald","Senior biotech analyst positions at Credit Suisse and Deutsche Bank","Research policy analyst and president at Marwood Group","Experience in investment banking and asset management at J.P. Morgan"] | ["Audit Committee","Nominating & Corporate Governance Committee"] | 2025 |